United States:
Pippins Quoted In Natural Products Insider On FDA Regulatory Issues
23 April 2019
Arnold & Porter
To print this article, all you need is to be registered or login on Mondaq.com.
Life Sciences and Healthcare Regulatory partner Raqiyyah Pippins was
recently quoted in Natural Products Insider on the regulatory
requirements for cannabidiol (CBD) in cosmetics, food additives,
and supplements. She also discussed how the recent departure of
Commissioner Scott Gottlieb from the FDA will impact the consumer
products industry.
» Read the full article on CBD
regulation.
» Read the full article on FDA former
Commissioner Scott Gottlieb.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...